StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
Publishing Date
2022 - 09 - 14
10
2022 - 09 - 13
2
Sector
Communications
1
Health technology
9
Manufacturing
1
Retail trade
1
Tags
Acquisition
4
Agreement
4
Alliances
3
America
3
Analytics
4
Application
4
Automotive
3
Battery
3
Biopharma
3
Cancer
5
Ceo
4
Clinical-trials-phase-ii
3
Cloud
3
Collaboration
3
Companies
3
Conference
16
Contract
3
Corporation
7
Day
3
Deadline
3
Designation
4
Disease
7
Drug
5
Earnings
3
Energy
4
Events
11
Expected
5
Financial
12
Genetown
4
Global
26
Group
5
Growth
19
Health
6
Innovation
4
Market
53
Meeting
9
N/a
248
Nasdaq
5
Offering
9
One
5
Partnership
4
Patent
4
People
8
Platform
5
Positive
4
Potential
4
Preclinical
4
Program
6
Report
16
Research
12
Results
11
Sales
5
Security
4
Services
5
Solutions
7
Study
7
Therapeutics
14
Treatment
12
Trial
7
Update
5
Entities
Abbvie inc.
1
Adverum biotechnologies, inc.
1
Alcon inc.
1
Bausch health companies inc.
1
Centessa pharmaceuticals plc - adr
1
Effector therapeutics inc
1
Glaxosmithkline plc
1
Ibio, inc.
1
Ligand pharmaceuticals incorporated
1
Medicinova, inc.
1
Novartis ag
1
Orange
1
Regenxbio inc.
1
Syros pharmaceuticals, inc.
1
Timber pharmaceuticals, inc.
1
Tracon pharmaceuticals, inc.
1
Walmart inc.
1
Symbols
ABBV
1
ADVM
1
ALC
1
BHC
1
CNTA
1
EFTR
1
FNCTF
1
GLAXF
1
GSK
1
IBIO
1
LGND
1
MNOV
1
NVS
1
NVSEF
1
RGNX
1
SYRS
1
TCON
1
TMBR
1
WMT
1
Exchanges
Amex
2
Nasdaq
8
Nyse
3
Crawled Date
2024 - 04 - 24
14
2024 - 03 - 19
12
2024 - 03 - 04
13
2023 - 12 - 12
13
2023 - 12 - 06
14
2023 - 11 - 27
12
2023 - 10 - 18
12
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
17
2023 - 09 - 20
12
2023 - 09 - 07
14
2023 - 06 - 26
13
2023 - 04 - 25
13
2023 - 04 - 17
14
2023 - 02 - 23
12
2023 - 01 - 30
16
2023 - 01 - 25
14
2022 - 11 - 17
12
2022 - 10 - 12
13
2022 - 09 - 14
12
2022 - 08 - 22
13
2022 - 05 - 17
13
2022 - 03 - 28
14
2022 - 01 - 24
16
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
14
2021 - 11 - 12
11
2021 - 11 - 01
12
2021 - 10 - 25
11
2021 - 10 - 19
11
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
13
2021 - 10 - 04
12
2021 - 09 - 30
11
2021 - 09 - 09
11
2021 - 09 - 07
12
2021 - 08 - 24
11
2021 - 07 - 13
11
2021 - 06 - 29
12
2021 - 06 - 28
11
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
13
2021 - 04 - 30
11
2021 - 04 - 15
11
2021 - 03 - 22
14
2020 - 12 - 15
14
2020 - 12 - 03
11
2020 - 12 - 02
12
2020 - 12 - 01
18
Crawled Time
00:00
1
01:00
1
10:00
1
12:20
1
14:00
3
14:20
2
16:00
1
19:00
1
21:00
1
Source
www.biospace.com
7
www.globenewswire.com
2
www.jupiterwellnessinc.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Treatment
crawled date :
2022 - 09 - 14
save search
USD 7.22 Bn growth expected in Myopia and Presbyopia Treatment Market -- Evolving Opportunities with AbbVie Inc. and Alcon Inc.
Published:
2022-09-14
(Crawled : 21:00)
- prnewswire.com
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
19.19%
|
O:
0.71%
H:
0.82%
C:
-0.31%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
21.49%
|
O:
0.32%
H:
2.79%
C:
1.8%
treatment
expected
growth
presbyopia
market
It All Comes Down To Science And Research With The Efficacy Of Jupiter Wellness’s Lineup Of Skin And Hair Treatment Drugs
Published:
2022-09-14
(Crawled : 19:00)
- jupiterwellnessinc.com
WMT
|
News
|
$59.87
1.32%
-0.23%
19M
|
Retail Trade
|
-56.2%
|
O:
0.1%
H:
0.07%
C:
-1.17%
treatment
research
skin
Sermonix Pharmaceuticals Shares Details of First-Ever Known Durable Complete Clinical Response in a Metastatic ER+/HER2- Breast Cancer Patient With an ESR1 Mutation After Prior CDK4/6 Inhibitor Treatment
Published:
2022-09-14
(Crawled : 16:00)
- biospace.com/
LGND
|
$70.87
1.4%
1.38%
150K
|
Health Technology
|
-23.2%
|
O:
0.44%
H:
0.48%
C:
-2.07%
treatment
response
cancer
esr1 mutation
her2-
her2
Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis
Published:
2022-09-14
(Crawled : 14:20)
- biospace.com/
TMBR
|
$0.3426
-2.69%
3K
|
Health Technology
|
180.49%
|
O:
5.69%
H:
34.23%
C:
7.31%
tmb-001
treatment
designation
positive
TRACON Pharmaceuticals Announces Fast Track Designation by the FDA for Envafolimab for the Treatment of the Soft Tissue Sarcoma Subtypes of UPS and MFS
Published:
2022-09-14
(Crawled : 14:20)
- biospace.com/
TCON
|
$1.895
2.43%
2.37%
65K
|
Health Technology
|
-2.63%
|
O:
4.21%
H:
1.52%
C:
-4.04%
treatment
fda
designation
soft tissue
fast track designation
Centessa Pharmaceuticals Announces Orphan Drug Designation Granted to SerpinPC for the Treatment of Hemophilia B
Published:
2022-09-14
(Crawled : 14:00)
- biospace.com/
CNTA
|
News
|
$9.475
0.8%
0.79%
2.2M
|
Manufacturing
|
131.92%
|
O:
0.94%
H:
9.53%
C:
7.91%
treatment
designation
drug
granted
GentiBio To Present Preclinical Data Demonstrating Technical Progress to Engineer Regulatory T Cells for the Prevention and Treatment of Autoimmune Diseases
Published:
2022-09-14
(Crawled : 14:00)
- biospace.com/
IBIO
|
$1.9
0.0%
99K
|
Health Technology
|
-75.32%
|
O:
-0.97%
H:
4.16%
C:
-4.89%
treatment
preclinical
Adverum Biotechnologies Announces First Subject Dosed with Ixo-vec in the Phase 2 LUNA Trial for the Treatment of Wet Age-Related Macular Degeneration
Published:
2022-09-14
(Crawled : 14:00)
- biospace.com/
ADVM
|
News
|
$10.19
-7.36%
-7.95%
310K
|
Health Technology
|
937.74%
|
O:
0.0%
H:
7.55%
C:
2.83%
treatment
macular
trial
phase 2
eFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
Published:
2022-09-14
(Crawled : 12:20)
- globenewswire.com
EFTR
|
$1.82
-6.19%
-6.59%
110K
|
|
204.22%
|
O:
3.58%
H:
2.95%
C:
-4.62%
covid-19
treatment
trial
therapeutics
phase 2b
Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published:
2022-09-14
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
27.09%
|
O:
-4.98%
H:
7.63%
C:
2.67%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
20.63%
|
O:
-0.55%
H:
0.42%
C:
-0.72%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
30.38%
|
O:
-0.6%
H:
0.41%
C:
-0.76%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
15.9%
|
O:
0.41%
H:
11.64%
C:
6.22%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-39.61%
|
O:
0.38%
H:
2.53%
C:
1.48%
treatment
global
macular
market
Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer
Published:
2022-09-13
(Crawled : 01:00)
- biospace.com/
SYRS
|
$5.055
-1.65%
-1.68%
90K
|
Health Technology
|
-29.62%
|
O:
21.87%
H:
3.93%
C:
-13.94%
sy-5609
treatment
fda
designation
drug
cancer
pancreatic
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Canada
Published:
2022-09-13
(Crawled : 00:00)
- globenewswire.com
MNOV
|
$1.33
-3.73%
8K
|
Health Technology
|
-37.56%
|
O:
2.82%
H:
2.74%
C:
-1.37%
mn-001
treatment
patent
canada
hypercholesterolemia
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.